[Experiences in the medical treatment of progressive myopia (author's transl)].
In order to judge the effect of anthocyanosides and vitamine E (Difrarel E) on refraction, visual acuity and eye-fundus, we treated 36 patients with this speciality in progressive myopia. After an observation period of 14.5 months an average increase of myopia by 0.53 dpt per eye was demonstrated. The final examination of 29 patients showed a stabilization of the fundus-alterations, as well as a stable, or an improved visual acuity respectively. In 7 patients a moderate deterioration of the partial or overall medical findings occured. Our observations allow the conclusion that Difrarel E achieves therapeutically valuable results in the treatment of progressive myopia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000872:Anthocyanins / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000188:drug therapy*; D013997:Time Factors; D014792:Visual Acuity / Q000187:drug effects; D014810:Vitamin E / Q000494:pharmacology / Q000627:therapeutic use
D000872:Anthocyanins; D004338:Drug Combinations; D014810:Vitamin E
Zur medikamentösen Terapie bei der progredienten Myopie.